Literature DB >> 5588333

Structure-activity relationship studies on mescaline. 3. The influence of the methoxy groups.

J R Smythies, R J Bradley, V S Johnston, F Benington, R D Morin, L C Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5588333     DOI： 10.1007/BF00403978

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  10 in total

1.  THE EFFECTS OF RING-METHYOXYL GROUPS ON BIOLOGICAL DEAMINATION OF PHENETHYLAMINES.

Authors:  L C CLARK; F BENINGTON; R D MORIN
Journal:  J Med Chem       Date:  1965-05       Impact factor: 7.446

2.  Phenomena of the hypokinetic rigid type caused by o-methylation of dopamine in the para-position.

Authors:  A M ERNST
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

3.  Neuromyal blocking action of mescaline.

Authors:  R T SCHOPP; W F KREUTTER; S V GUZAK
Journal:  Am J Physiol       Date:  1961-06

4.  Effects of amino acid feedings in schizophrenic patients treated with iproniazid.

Authors:  W POLLIN; P V CARDON; S S KETY
Journal:  Science       Date:  1961-01-13       Impact factor: 47.728

5.  The effect of mescaline upon the conditioned avoidance response in the rat.

Authors:  J R Smythies; E A Sykes
Journal:  Psychopharmacologia       Date:  1964-09-11

6.  Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines.

Authors:  A T Shulgin
Journal:  Experientia       Date:  1964-07-15

7.  Relation between the structure of certain methoxyphenylethylaminederivatives and the occurrence of a hypokinetic rigid syndrome.

Authors:  A M Ernst
Journal:  Psychopharmacologia       Date:  1965-05-21

8.  Effects of 3,4-dimethoxyphenylethylamine in man.

Authors:  L E Hollister; A J Friedhoff
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

9.  Structure-activity relationship studies on mescaline: the effect of dimethoxyphenylethylamine and N:N-dimethyl mescaline on the conditioned avoidance response in the rat.

Authors:  J R Smythies; E A Sykes
Journal:  Psychopharmacologia       Date:  1966

10.  Structure-activity relationship studies on mescaline. II. Tolerance and cross-tolerance between mescaline and its analogues in the rat.

Authors:  J R Smythies; E A Sykes; C P Lord
Journal:  Psychopharmacologia       Date:  1966
  10 in total
  8 in total

1.  Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.

Authors:  S T Christian; L D McClain; R D Morin; F Benington
Journal:  Experientia       Date:  1975-08-15

2.  Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.

Authors:  R G Browne; R T Harris; B T Ho
Journal:  Psychopharmacologia       Date:  1974

3.  Screening hallucinogenic drugs II. Systematic study of two behavioral tests.

Authors:  H M Calil
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

4.  Macromerine, normacromerine and bisnormacromerine: non-psychoactive methylated derivatives of norepinephrine.

Authors:  W H Vogel; B D Evans; E M Bonnem; J F Fischer; J L McLaughlin
Journal:  Psychopharmacologia       Date:  1973-05-21

5.  Autoradiographic studies on the distribution of 3H-2,3,4-trimethoxy-beta-phenylethylamine in the mouse.

Authors:  H Korr; N Seiler
Journal:  Psychopharmacologia       Date:  1976

6.  Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Authors:  Adam L Halberstadt; Muhammad Chatha; Stephen J Chapman; Simon D Brandt
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

7.  Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

8.  The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Authors:  Malin Vedøy Uthaug; Alan K Davis; Trevor Forrest Haas; Dawn Davis; Sean B Dolan; Rafael Lancelotta; Christopher Timmermann; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2021-05-05       Impact factor: 4.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.